Renal Disease in Obesity, Metabolic Syndrome and Diabesity

Navarro-Díaz, Maruja; Rodríguez-Rodríguez, Rosa

doi:10.1007/978-3-319-93521-8_5

Cited by 2 publications

(1 citation statement)

References 85 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, this study showed that the DN groups had higher values of BMI than the control and diabetic without DN groups. This is in agreement with Porrini et al [16] who mentioned that obesity with a BMI of > 30 kg/ m 2 is a major risk factor for DN. This study showed that patients with DN had longer disease duration than those without DN.…”

Section: Discussionsupporting

confidence: 92%

Study of serum pentraxin 3 level in patients with diabetic nephropathy

et al. 2020

View full text Add to dashboard Cite

Background: Pentraxin 3 (PTX3), a member of a superfamily of conserved proteins called pentraxins. PTX3 and Creactive protein (CRP) are members of this family and play an important role in the innate immune system. PTX3 is classified as a long pentraxin, while CRP is a short pentraxin. PTX3 is reported to be a vascular inflammatory marker providing prognostic information of vasculopathy, such as diabetic nephropathy (DN). The purpose of this study is to evaluate the association between serum PTX3 concentrations and the development and/or progression of DN. A total number of 66 patients with type 2 diabetes mellitus (T2DM) and 22 healthy subjects were enrolled in this study. Patients with T2DM were divided, according to the levels of urinary albumin/creatinine ratio (UACR), into three groups: normoalbuminuric, microalbuminuric, and macroalbuminuric groups. Serum PTX3 and high-sensitivity C-reactive protein (hs-CRP) concentrations were determined using ELISA kits. Results: Serum PTX3 and hs-CRP concentrations were significantly higher in patients with T2DM compared with the controls. Furthermore, serum PTX3 concentrations were significantly higher in macroalbuminuric patients than in microalbuminuric patients (P < 0.001) and also were significantly higher in microalbuminuric patients than in normoalbuminuric patients (P < 0.001). However, there were no significant differences between controls and T2DM patients with normoalbuminuria regarding serum PTX3 concentrations (P > 0.05). Moreover, like PTX3, hs-CRP concentrations were higher in microalbuminuric patients than in normoalbuminuric patients (P < 0.05), and also, there were no significant differences between controls and T2DM patients with normoalbuminuria regarding hs-CRP concentrations (P > 0.05). But, unlike PTX3, there were no significant differences between macroalbuminuric and microalbuminuric patients regarding hs-CRP concentrations (P > 0.05). Conclusions: Serum PTX3 is positively associated with DN development and progression, and may be a more accurate predictor of DN development than hs-CRP as it can discriminate between macroalbuminuric and microalbuminuric DN patients, while hs-CRP cannot.

show abstract

Section: Discussionsupporting

confidence: 92%